Clene (CLNNW) had the highest return between January 8, 2024 and January 22, 2024 by a small-cap US stock, returning 83.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Clene (CLNNW) | 1/8/2024 - 1/22/2024 | 83.67% |
Edgewise Therapeutics (EWTX) | 1/8/2024 - 1/22/2024 | 55.66% |
Praxis Precision Medicines (PRAX) | 1/8/2024 - 1/22/2024 | 48.62% |
Real Brokerage (REAX) | 1/8/2024 - 1/22/2024 | 46.33% |
Establishment Labs (ESTA) | 1/8/2024 - 1/22/2024 | 40.66% |
Immunome (IMNM) | 1/8/2024 - 1/22/2024 | 37.89% |
Net Lease Office Properties (NLOP) | 1/8/2024 - 1/22/2024 | 36.76% |
Ardelyx (ARDX) | 1/8/2024 - 1/22/2024 | 35.69% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/8/2024 - 1/22/2024 | 35.13% |
Oric Pharmaceuticals (ORIC) | 1/8/2024 - 1/22/2024 | 33.72% |
Neuropace (NPCE) | 1/8/2024 - 1/22/2024 | 33.69% |
Innodata (INOD) | 1/8/2024 - 1/22/2024 | 32.19% |
Tourmaline Bio (TRML) | 1/8/2024 - 1/22/2024 | 31.9% |
Eos Energy Enterprises (EOSEW) | 1/8/2024 - 1/22/2024 | 31.58% |
Standard Biotools (LAB) | 1/8/2024 - 1/22/2024 | 29.95% |
Tarsus Pharmaceuticals (TARS) | 1/8/2024 - 1/22/2024 | 29.36% |
Clearpoint Neuro (CLPT) | 1/8/2024 - 1/22/2024 | 27.63% |
Dianthus Therapeutics (DNTH) | 1/8/2024 - 1/22/2024 | 27.63% |
Acm Research (ACMR) | 1/8/2024 - 1/22/2024 | 26.61% |
Penguin Solutions (PENG) | 1/8/2024 - 1/22/2024 | 25.81% |
Verastem (VSTM) | 1/8/2024 - 1/22/2024 | 25.8% |
Ideaya Biosciences (IDYA) | 1/8/2024 - 1/22/2024 | 24.29% |
Sage Therapeutic (SAGE) | 1/8/2024 - 1/22/2024 | 23.74% |
Grupo Supervielle (SUPV) | 1/8/2024 - 1/22/2024 | 23.67% |
ASP Isotopes Inc Common Stock (ASPI) | 1/8/2024 - 1/22/2024 | 23.2% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
